| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |